MedTrace Logo

Regional Data Exchange to Improve Medication Safety

NCT01239121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 402

Last updated 2016-08-15

Study results available
· View outcomes & findings →

Summary

Medication reconciliation, a process by which a provider obtains and documents a thorough medication history with specific attention to comparing current and previous medication use, can prevent medication-related errors and harm. The aims of this study are: 1) To adapt medication reconciliation to include information from a computerized regional health information exchange (RHIO) in the Bronx, 2) To conduct a trial of the adapted medication reconciliation process and examine effects on medication errors, harm, and hospital costs, and 3) To identify factors that are barriers to adoption of the RHIO tool by James J. Peters (Bronx) VA providers. Findings from this project will provide an understanding of the effect of the RHIO tool on reducing harmful VA and non-VA medication use. It will also provide information on the feasibility of incorporating RHIO tool use into every day work flow for pharmacists and physicians.

Conditions

  • Drug Toxicity

Interventions

OTHER

HIE-Enhanced Medication Reconciliation

Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist

OTHER

Optimal Medication Reconciliation without HIE

Medication reconciliation implemented by a pharmacist without regional health information exchange

Sponsors & Collaborators

  • University of Victoria

    collaborator OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Kenneth S Boockvar, MD MS · James J. Peters Veterans Affairs Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01239121 on ClinicalTrials.gov